Some large health systems, including Stanford Health Care and Penn Medicine, are building AI-powered chatbots that help clinicians query patients' health records.
Third round of CMS drug price negotiations target 15 drugs, including Trulicity, Rexulti, Biktarvy, Xolair and Cosentyx. Prices would take effect in 2028.